0001415889-24-016092.txt : 20240607 0001415889-24-016092.hdr.sgml : 20240607 20240607210419 ACCESSION NUMBER: 0001415889-24-016092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McLoughlin Margaret CENTRAL INDEX KEY: 0001770823 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38890 FILM NUMBER: 241031305 MAIL ADDRESS: STREET 1: C/O CORTEXYME, INC. STREET 2: 269 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quince Therapeutics, Inc. CENTRAL INDEX KEY: 0001662774 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 901024039 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 273 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-910-5717 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 273 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Cortexyme, Inc. DATE OF NAME CHANGE: 20160104 4 1 form4-06082024_010616.xml X0508 4 2024-06-05 0001662774 Quince Therapeutics, Inc. QNCX 0001770823 McLoughlin Margaret C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD, SUITE 273 SOUTH SAN FRANCISCO CA 94080 true false false false 0 Employee Stock Option (right to buy) 0.82 2024-06-05 4 A 0 27000 0 A 2025-06-05 2034-06-05 Common Stock 27000 27000 D 100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date. /s/ Brendan Hannah, Attorney-in-Fact for Margaret McLoughlin 2024-06-07